Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early‐stage prostate cancer

E-ISSN： 1097-0142|119|19|3446-3453

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.19, 2013-10, pp. : 3446-3453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Variation in treatment associated with life expectancy in a population‐based cohort of men with early‐stage prostate cancer

CANCER, Vol. 120, Iss. 23, 2014-12 ,pp. : 3642-3650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Overtreatment of men with early‐stage prostate cancer and limited life expectancy

CANCER, Vol. 120, Iss. 23, 2014-12 ,pp. : 3592-3594

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of early‐stage prostate cancer among rural and urban patients

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 3067-3075

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative effectiveness of aggressive versus nonaggressive treatment among men with early‐stage prostate cancer and differing comorbid disease burdens at diagnosis

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2432-2439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expectant management for men with early stage prostate cancer

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 4, 2015-07 ,pp. : 264-282

John Wiley & Sons Inc

Access to resources Recommend Favorite